Skip to content
Hello You WellnessMiami
Call

HRT, BHRT & Testosterone

Hormone therapy

In-person, physician-supervised hormone replacement for men with clinically low testosterone and women navigating perimenopause and menopause—dosed from your labs and your symptoms, monitored on a defined cadence, framed around quality of life.

Medical oversightSW Miami

Program pricing quoted in full before you commit—no silent recurring charges.

Clinical oversight

Clinical oversight by [PROVIDER_NAME], [CREDENTIALS] — Hello You Wellness Center, 9660 SW 72nd St, Miami, FL 33173.

Hormones are not a lifestyle purchase. Hormone replacement therapy — for men with clinically low testosterone, and for women navigating perimenopause and menopause — is medicine. Done well, it can meaningfully improve day-to-day quality of life. Done casually, it can create real risk. We frame this work around symptom management and quality of life. We do not promise disease prevention.

Testosterone therapy for men (TRT)

If you are a man over roughly 35 and something feels off — persistent fatigue that sleep does not fix, dropping libido, mood flatness, harder time holding muscle, mental fog that used to not be there — clinically low testosterone is one of several things worth ruling in or out. It is not the only cause of those symptoms. That is exactly why the process starts with labs, not a script.

Symptoms we hear most often

  • Fatigue that persists despite adequate sleep
  • Reduced libido or sexual function
  • Depressed mood, irritability, or motivational flatness
  • Loss of muscle mass or strength; new central weight gain
  • Cognitive fog, reduced sharpness
  • Sleep disruption

None of these on their own diagnoses low T. Together, over time, they warrant evaluation.

Diagnostic labs

Before we discuss any therapy, we run a baseline panel. Typical labs include:

  • Total testosterone (morning draw, ideally repeated on a second day for confirmation)
  • Free testosterone
  • Sex hormone-binding globulin (SHBG)
  • Estradiol (sensitive assay)
  • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Prostate-specific antigen (PSA) — baseline before initiating therapy
  • Comprehensive metabolic panel and complete blood count (hematocrit matters on TRT)
  • Lipid panel

Delivery options

There is no single "best" delivery method — the right choice depends on your labs, your lifestyle, and how your body responds. We discuss all three at consult.

Injection (testosterone cypionate or testosterone enanthate)

Most common. Weekly or twice-weekly intramuscular or subcutaneous injection. Steady, adjustable, cost-effective. Requires either self-administration at home or in-clinic visits.

Pellet implants

Subcutaneous pellets placed in-office, typically providing 3-6 months of steady release. Convenient; less dose flexibility mid-cycle.

Topical gel

Daily application. Non-injection option; requires care to avoid transfer to partners or children.

Monitoring cadence

TRT without monitoring is not TRT — it is unsupervised hormone use. Our standard cadence:

  • 6 weeks after initiation:Repeat total T, free T, estradiol, hematocrit.
  • 3 months:Full panel including PSA.
  • Quarterly thereafter:Rotating panel; PSA and hematocrit at minimum on the schedule your physician sets.

Program pricing

Men's TRT programs start at $499/program.

Pricing includes physician evaluation, ongoing oversight, and program-defined follow-up. Lab costs and specific medication compounding may be quoted separately depending on your protocol. We quote the full program before you commit — no surprise recurring charges.

Hormone therapy for women (HRT and BHRT)

Perimenopause often starts earlier than women expect — sometimes in the late 30s, more commonly in the 40s — and menopause itself is not a single day but a transition. Symptoms range from disruptive to debilitating, and they are legitimate targets for treatment. You do not have to "just get through it."

Symptoms we hear most often

  • Hot flashes and night sweats (vasomotor symptoms)
  • Sleep disruption
  • Mood changes, irritability, new anxiety
  • Vaginal dryness, discomfort, painful intercourse (genitourinary syndrome of menopause)
  • Cognitive changes — word-finding, focus
  • Changes in menstrual cycle regularity or flow (perimenopause)
  • New or worsening joint aches

Diagnostic labs and screening

Before initiating hormone therapy, we review or order:

  • FSH, LH, estradiol, progesterone
  • Total and free testosterone, SHBG (where relevant)
  • Thyroid panel (TSH, free T4)
  • Lipid panel, comprehensive metabolic panel, CBC
  • Current mammogram and pap status
  • Personal and family history of breast, ovarian, endometrial cancer; clotting disorders; cardiovascular events

Estrogen, progesterone, and how we pair them

For women with an intact uterus, unopposed estrogen therapy carries endometrial risk. Progesterone is paired with estrogen therapy in that setting. This is standard of care — not optional, not a preference.

Estradiol

Transdermal patch, topical gel, oral tablet, or pellet implant. Transdermal routes have a different risk profile than oral routes and are often preferred in patients with specific cardiovascular considerations.

Progesterone

Oral micronized progesterone or topical formulations, dosed cyclically or continuously depending on your protocol.

Additional hormonal support

For some women, additional hormonal support beyond estrogen and progesterone may be discussed during consultation. Note: no FDA-approved testosterone product exists for women in the U.S.

Monitoring cadence for women

  • 6-12 weeks after initiation or dose change:Symptom review, targeted labs.
  • 6 months, then annually:Full review including cancer screening currency (mammogram, pap per age-appropriate guidelines), lipids, metabolic panel.
  • Ongoing:Any new breast changes, unexpected vaginal bleeding, or leg pain/swelling triggers immediate re-evaluation, not the next scheduled visit.

BHRT — what "bioidentical" actually means

Bioidentical hormone replacement therapy (BHRT) is a widely marketed category, and it is worth being honest about what the word means.

"Bioidentical" describes molecular structure. A bioidentical hormone has the same molecular structure as the hormone your body produces endogenously. Estradiol is estradiol whether it is FDA-approved and manufactured by a large pharmaceutical company or compounded by a 503A pharmacy — the molecule is the same.

"Bioidentical" does not mean "natural," "safer," or "free of risk." This is the marketing myth. Compounded BHRT is not automatically safer than FDA-approved conventional HRT. In fact, most compounded BHRT formulations lack FDA approval, meaning they have not been through the same efficacy, dosing consistency, and safety review that approved products have.

We prescribe both FDA-approved bioidentical products (yes — many mainstream HRT products are already bioidentical, such as estradiol patches and micronized progesterone) and, where clinically appropriate, compounded formulations. The distinction we make with patients is real and evidence-based, not marketed.

Contraindications and cautions

HRT is not appropriate for every patient. We will not prescribe (or will require specialty clearance before considering) in the presence of:

  • Active or recent hormone-sensitive cancers — breast, prostate (for testosterone), endometrial, ovarian
  • Active thromboembolic disease or high-risk clotting history
  • Uncontrolled hypertension
  • Undiagnosed vaginal bleeding (must be worked up first)
  • Active liver disease
  • Pregnancy or breastfeeding
  • Recent stroke or myocardial infarction

For men considering TRT: unaddressed severe sleep apnea, elevated hematocrit, and abnormal PSA warrant workup before initiation.

Pricing transparency

Men's TRT programs

Starts at $499/program

Includes physician evaluation and defined ongoing oversight; medication and lab costs may be quoted separately.

Women's HRT and BHRT programs

Quoted at consult

Pricing varies by delivery method, whether the formulation is FDA-approved or compounded, and monitoring intensity.

You will receive a full quote before you commit. We do not run silent auto-charges.

Why in-person hormone care matters

Telehealth HRT and TRT services have expanded access, and for some patients that model works. What we offer is different, not better in every case: in-person consultation, in-clinic labs at a SW Miami location you can drive to, physician follow-ups you can look someone in the eye for, and a chart that stays with a specific practice rather than a rotating national roster. If you value that model — particularly for a therapy that will likely be ongoing — that is what we are built to provide.

Also see our Aesthetics services — TRT was previously listed there as part of our broader hormone and wellness program; hormone therapy is now home here.

What you can expect

Initial consults are approximately 45-60 minutes—symptom review, history, and goals.

  • Physician-supervised protocols dosed from labs and symptoms
  • Defined monitoring cadence—not fire-and-forget prescribing
  • In-clinic labs and follow-ups you can actually walk into
  • Honest framing: symptom management and quality of life, not disease prevention

Ideal for guests who want…

  • Men over ~35 with fatigue, low libido, mood flatness, or new central weight gain
  • Women navigating perimenopause or menopause—vasomotor symptoms, sleep, mood, or GSM
  • Anyone who wants in-person hormone care over a telehealth-only model

Need help choosing?

Tell us your goals when you call or message—we will route you to the right provider and visit length.

How it works

Getting Started Is Easy

1

Step 1: Consult

Symptom review, health history, and goals conversation. About 45-60 minutes. No pressure to start therapy the same day.

2

Step 2: Comprehensive labs

Drawn in-clinic or at partnered lab. Results typically available within several business days, then reviewed by your physician against your symptom picture.

3

Step 3: Protocol and monitoring

If HRT is appropriate, we discuss delivery options and start a defined protocol. Follow-ups at 6 weeks, 3 months, then a rotating schedule appropriate to your therapy.

Common questions

Still deciding? These answers mirror what we share at the concierge desk.

Full FAQ library

Possibly — and the only way to know is with labs and a physician evaluation. Symptoms alone do not diagnose low T, and low T alone (without symptoms) does not always warrant treatment. The right answer for you comes from combining both.

HRT (hormone replacement therapy) is the umbrella term. BHRT (bioidentical hormone replacement therapy) refers specifically to hormones that share the same molecular structure as those your body produces. BHRT can be FDA-approved (many are) or compounded. "Bioidentical" describes chemistry, not safety.

Our TRT programs start at $499/program. That is a program price, not a per-visit price. Program pricing includes physician evaluation and defined ongoing oversight; medication and lab costs may be quoted separately depending on your protocol. We quote the full amount before you commit.

Neither is universally better. Injections offer dose flexibility and lower per-cycle cost but require ongoing administration. Pellets offer 3-6 months of steady release with no weekly routine but less mid-cycle adjustability. Your labs, lifestyle, and preferences drive the choice—we discuss both at consult.

No — that is a marketing claim, not a clinical finding. Bioidentical hormones share molecular structure with endogenous hormones, but that does not translate to reduced risk. FDA-approved products (many of which are already bioidentical) have the benefit of standardized dosing and formal safety review. Compounded formulations do not. We discuss the trade-offs candidly in consult.

When symptoms of perimenopause or menopause are affecting quality of life and other causes have been considered. Onset varies widely—some patients present in their late 30s, most in their 40s or 50s. There is no single "right age." What matters is symptoms, labs, and a real risk/benefit conversation with your physician.

Men on TRT: at 6 weeks, 3 months, then quarterly rotating panels. Women on HRT: at 6-12 weeks after initiation or dose change, then 6 months, then annually—with immediate re-evaluation for any concerning symptom (new breast changes, unexpected vaginal bleeding, leg pain or swelling).

Ready for your hormone therapy visit?

Secure a consultation or treatment block—our team confirms details within one business day.

CallTake the quizBook a visit